UAMY vs. VEON

Last updated Apr 1, 2026

Compare and contrast key facts about United States Antimony Corporation (UAMY) and VEON Ltd. (VEON).

Performance

UAMY vs. VEON - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United States Antimony Corporation (UAMY) and VEON Ltd. (VEON). The values are adjusted to include any dividend payments, if applicable.

UAMY vs. VEON - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
UAMY United States Antimony Corporation	73.90%	183.62%	610.84%	-48.86%	-2.19%	-4.64%	35.58%	-33.62%	81.25%	27.49%
VEON VEON Ltd.	-11.93%	31.10%	103.55%	60.82%	-71.35%	13.25%	-37.09%	18.88%	-34.17%	5.59%

Fundamentals

Market Cap UAMY : $1.08B VEON : $2.45B
EPS UAMY : -$0.03 VEON : $8.32
PS Ratio UAMY : 27.74 VEON : 0.67
PB Ratio UAMY : 7.66 VEON : 1.83
Total Revenue (TTM) UAMY : $39.26M VEON : $4.41B
Gross Profit (TTM) UAMY : $9.87M VEON : $3.68B
EBITDA (TTM) UAMY : -$6.89M VEON : $1.61B

Returns By Period

In the year-to-date period, UAMY achieves a 73.90% return, which is significantly higher than VEON's -11.93% return. Over the past 10 years, UAMY has outperformed VEON with an annualized return of 43.25%, while VEON has yielded a comparatively lower -5.20% annualized return.

UAMY

• 1D: 10.93%
• 1M: -2.35%
• YTD: 73.90%
• 6M: 40.81%
• 1Y: 296.82%
• 3Y*: 184.93%
• 5Y*: 48.97%
• 10Y*: 43.25%

VEON

• 1D: 3.39%
• 1M: -17.16%
• YTD: -11.93%
• 6M: -14.94%
• 1Y: 6.17%
• 3Y*: 37.73%
• 5Y*: 1.02%
• 10Y*: -5.20%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

UAMY vs. VEON — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UAMY

UAMY Risk / Return Rank: 88
UAMY Sharpe Ratio Rank: 93
UAMY Sortino Ratio Rank: 90
UAMY Omega Ratio Rank: 85
UAMY Calmar Ratio Rank: 90
UAMY Martin Ratio Rank: 84

VEON

VEON Risk / Return Rank: 45
VEON Sharpe Ratio Rank: 46
VEON Sortino Ratio Rank: 45
VEON Omega Ratio Rank: 44
VEON Calmar Ratio Rank: 44
VEON Martin Ratio Rank: 44

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UAMY vs. VEON - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for United States Antimony Corporation (UAMY) and VEON Ltd. (VEON). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	UAMY	VEON	Difference
Sharpe ratio Return per unit of total volatility	2.28	0.11	+2.17
Sortino ratio Return per unit of downside risk	2.80	0.57	+2.23
Omega ratio Gain probability vs. loss probability	1.32	1.08	+0.25
Calmar ratio Return relative to maximum drawdown	3.81	0.09	+3.72
Martin ratio Return relative to average drawdown	7.11	0.19	+6.93
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

UAMY vs. VEON - Sharpe Ratio Comparison

The current UAMY Sharpe Ratio is 2.28, which is higher than the VEON Sharpe Ratio of 0.11. The chart below compares the historical Sharpe Ratios of UAMY and VEON, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	UAMY	VEON	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.28	0.11	+2.17
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.53	0.01	+0.51
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.43	-0.09	+0.53
Sharpe Ratio (All Time) Calculated using the full available price history	0.07	0.04	+0.03

Correlation

The correlation between UAMY and VEON is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

UAMY vs. VEON - Dividend Comparison

Neither UAMY nor VEON has paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
UAMY United States Antimony Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
VEON VEON Ltd.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	7.62%	9.58%	9.47%	5.97%	0.68%	0.80%

Drawdowns

UAMY vs. VEON - Drawdown Comparison

The maximum UAMY drawdown since its inception was -96.44%, roughly equal to the maximum VEON drawdown of -98.74%. Use the drawdown chart below to compare losses from any high point for UAMY and VEON.

Drawdown Indicators

	UAMY	VEON	Difference
Max Drawdown Largest peak-to-trough decline	-96.44%	-98.74%	+2.30%
Max Drawdown (1Y) Largest decline over 1 year	-74.30%	-32.15%	-42.15%
Max Drawdown (5Y) Largest decline over 5 years	-84.49%	-88.66%	+4.17%
Max Drawdown (10Y) Largest decline over 10 years	-89.76%	-92.52%	+2.76%
Current Drawdown Current decline from peak	-50.03%	-91.14%	+41.11%
Average Drawdown Average peak-to-trough decline	-66.58%	-62.42%	-4.16%
Ulcer Index Depth and duration of drawdowns from previous peaks	39.77%	15.65%	+24.12%

Volatility

UAMY vs. VEON - Volatility Comparison

United States Antimony Corporation (UAMY) has a higher volatility of 40.32% compared to VEON Ltd. (VEON) at 25.46%. This indicates that UAMY's price experiences larger fluctuations and is considered to be riskier than VEON based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UAMY	VEON	Difference
Volatility (1M) Calculated over the trailing 1-month period	40.32%	25.46%	+14.86%
Volatility (6M) Calculated over the trailing 6-month period	107.33%	36.07%	+71.26%
Volatility (1Y) Calculated over the trailing 1-year period	131.50%	58.19%	+73.31%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	93.58%	68.87%	+24.71%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	100.37%	55.91%	+44.46%

Financials

UAMY vs. VEON - Profitability Comparison

The chart below illustrates the profitability comparison between United States Antimony Corporation and VEON Ltd. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

UAMY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, United States Antimony Corporation reported a gross profit of 2.65M and revenue of 13.03M. Therefore, the gross margin over that period was 20.3%.

VEON - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, VEON Ltd. reported a gross profit of 815.31M and revenue of 1.18B. Therefore, the gross margin over that period was 68.9%.

UAMY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, United States Antimony Corporation reported an operating income of -3.92M and revenue of 13.03M, resulting in an operating margin of -30.1%.

VEON - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, VEON Ltd. reported an operating income of 319.26M and revenue of 1.18B, resulting in an operating margin of 27.0%.

UAMY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, United States Antimony Corporation reported a net income of -286.91K and revenue of 13.03M, resulting in a net margin of -2.2%.

VEON - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, VEON Ltd. reported a net income of -31.32M and revenue of 1.18B, resulting in a net margin of -2.7%.